BRIGHT LIGHT THERAPY IN SELECTED NEUROPSYCHIATRIC AND SLEEP-RELATED CONDITIONS: A NARRATIVE REVIEW
Authors:
- Hanna MaruchniakHMHanna Maruchniak
- Wiktoria MarzecWMWiktoria Marzec
- Paulina BiedrońPBPaulina Biedroń
- Anna SkrzypekASAnna Skrzypek
- Maciej HutkowskiMHMaciej Hutkowski
- Mikołaj ZbrożekMZMikołaj Zbrożek
- Zuzanna ChwostekZCZuzanna Chwostek
- Bartłomiej KosiarskiBKBartłomiej Kosiarski
- Patrycja MarkowiczPMPatrycja Markowicz
- Krzysztof BiłykKBKrzysztof Biłyk
Open Access
- 30 March 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Abstract
Bright light therapy (BLT), defined as timed exposure to high-intensity light, is an established nonpharmacological treatment for seasonal affective disorder (SAD) and is increasingly being investigated in other areas of neuropsychiatry and sleep medicine. This narrative review synthesizes evidence published between 2015 and 2025 on the clinical applications of BLT in SAD, non-seasonal major depressive disorder, bipolar depression, shift-work-related circadian misalignment, sleep and selected non-motor symptoms of Parkinson’s disease. Relevant English-language literature was identified through PubMed and Google Scholar, with emphasis on systematic reviews, meta-analyses and randomized controlled trials. The strongest evidence supports BLT in winter-pattern SAD, where it remains first-line acute treatment associated with clinically meaningful symptom improvement. In non-seasonal major depressive disorder, pooled findings indicate a small-to-moderate antidepressant effect, although outcomes are more heterogeneous and seem to be influenced by treatment timing, chronotype and ambient light exposure. In bipolar depression, adjunctive BLT administered under mood-stabilizer coverage shows benefit and is generally well tolerated, with low short-term rates of manic or hypomanic switching when conservative protocols are used. In shift-work-related circadian disruption, BLT is associated with modest sleep benefits and measurable circadian phase delay, supporting its use as a strategy for circadian adaptation. In Parkinson’s disease, available studies suggest benefit for sleep disturbance and excessive daytime sleepiness, whereas effects on mood and other non-motor symptoms remain less consistent. Overall, BLT appears to be a clinically meaningful and feasible intervention across multiple conditions, although broader implementation is limited by protocol heterogeneity, biologically active control-light designs and limited long-term follow-up.Keywords
This publication has 26 references indexed in Scilit:
- Bright Light Therapy for Nonseasonal Depressive DisordersJAMA Psychiatry, 2025
- Treatment measures for seasonal affective disorder: A network meta-analysisJournal of Affective Disorders, 2024
- The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsSleep Medicine, 2021
- Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta‐analysis of randomized controlled trialsBrain and Behavior, 2020
- Light therapy in non-seasonal depression: An update meta-analysisPsychiatry Research, 2020
- Bright light therapy with a head-mounted device for anxiety, depression, sleepiness and fatigue in patients with Parkinson’s diseaseActa Neurologica Belgica, 2019
- Patterns of depressive symptom remission during the treatment of seasonal affective disorder with cognitive-behavioral therapy or light therapyDepression and Anxiety, 2018
- Efficacy of bright light therapy in bipolar depressionPsychiatry Research, 2018
- Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson DiseaseJAMA Neurology, 2017
- Bright light therapy for nonseasonal depression: Meta-analysis of clinical trialsJournal of Affective Disorders, 2016